GLP-1 receptor agonists were designed with these challenges in mind, which is why currently approved medications rely on injectable or highly specialized oral delivery systems
Simon Cork, Senior Lecturer in Physiology, Anglia Ruskin University This article is republished from The Conversation under a Creative Commons license
Nausea, vomiting, diarrhea, and constipation are the most frequently reported side effects
In this review, we will discuss considerations for the use of glucose-lowering treatments in older adults, with particular focus on the use of basal insulin and glucagon-like peptide-1 receptor agonists, and the rationale for the use of combination therapy comprising these agents
Although supplementation with antioxidants in patients with Down syndrome improves oxidative stress biomarkers and the overall antioxidant status of an organism